Revolution Medicines (RVMD) Price to Earnings (2020 - 2026)

Revolution Medicines (RVMD) Price to Earnings (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Oculis Holding AG	66,861.65 Bn	66,861.36 Bn	-	-31.20 Bn
2	Nanobiotix	1,912.79 Bn	1,912.72 Bn	-	-70,009.43
3	Akari Therapeutics	1,071.19 Bn	1,071.19 Bn	-	-36,469.71
4	BeOne Medicines	469.11 Bn	464.32 Bn	1.35 Bn	914.40
5	Vertex Pharmaceuticals	123.03 Bn	115.78 Bn	2.59 Bn	28.36
6	Regeneron Pharmaceuticals	70.13 Bn	61.37 Bn	3.31 Bn	15.85
7	Belite Bio	63.44 Bn	63.44 Bn	-	373.20 Bn
8	Argenx Se	55.97 Bn	50.78 Bn	1.41 Bn	32.63
9	Alnylam Pharmaceuticals	37.53 Bn	34.52 Bn	959.66 Mn	69.00
10	Revolution Medicines	37.50 Bn	37.50 Bn	-	-27.34

Download Data